Madrigal Pharmaceuticals Reports Second-Quarter 2025 Financial Results and Provides Corporate Updates

Go back to Madrigal Pharmaceuticals Reports Second-Quarter 2025 Financial Results and Provides Corporate Updates
(NASDAQ: MDGL) Delayed: 513.43 --0 (-0%)
Previous Close $513.43    52 Week High $18.24 
Open $513.43    52 Week Low $6.60 
Day High $513.43    P/E N/A 
Day Low $513.43    EPS $0.00 
Volume